Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
8,789,399
-
Share change
-
+384,868
-
Total reported value
-
$715,910,314
-
Put/Call ratio
-
114%
-
Price per share
-
$82.33
-
Number of holders
-
92
-
Value change
-
+$32,118,674
-
Number of buys
-
58
-
Number of sells
-
31
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2014
As of 30 Jun 2014,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,789,399 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, FIRST TRUST ADVISORS LP, UBS AG, BANK OF AMERICA CORP /DE/, RiverFront Investment Group, LLC, RAYMOND JAMES & ASSOCIATES, GOLDMAN SACHS GROUP INC, LPL Financial LLC, and ROYAL BANK OF CANADA.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.